Jonathan Rosenberg

Papers authored by Jonathan Rosenberg

This paper is available in a repository.

2015 Patrizia Pinciroli, Helen Won, Gopa Iyer, Silvana Canevari, Maurizio Colecchia, Patrizia Giannatempo, Daniele Raggi, Marco A. Pierotti, Filippo G. De Braud, David B. Solit

, Jonathan E. Rosenberg

, Michael F. Berger, Andrea Necchi

Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma

Download from europepmc.org

This paper was not found in any repository, but could be made available legally by the author.

Eliezer M. Van Allen, Levi A. Garraway, Jonathan E. Rosenberg

Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

Upload

This paper is made freely available by the publisher.

Joaquim Bellmunt, Lillian Werner, Jeffrey J. Leow, Stephanie A. Mullane, André P. Fay, Markus Riester, Paul Van Hummelen, Mary-Ellen Taplin, Toni K. Choueiri, Eliezer Van Allen, Jonathan Rosenberg

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors

Download from doi.org

Guru Sonpavde, Gregory R. Pond, Stephanie Mullane, Angela Q. Qu, Giuseppe Di Lorenzo, Piera Federico, Andrea Necchi, Jonathan E. Rosenberg

, Joaquim Bellmunt, Toni K. Choueiri

Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design

Upload

Rana R. McKay, Kathryn P. Gray, Julia H. Hayes, Glenn J. Bubley, Jonathan E. Rosenberg

, Arif Hussain, Philip W. Kantoff, Mary‐Ellen Taplin

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Matthew D. Galsky, Sumanta K. Pal, Simon Chowdhury, Lauren C. Harshman, Simon J. Crabb, Yu-Ning Wong, Evan Y. Yu, Thomas Powles, Erin L. Moshier, Sylvain Ladoire, Syed A. Hussain

, Neeraj Agarwal, Ulka N. Vaishampayan, Federica Recine, Dominik Berthold and 5 other authors

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer

Upload

Richard M. Bambury, Ami S. Bhatt, Markus Riester, Chandra Sekhar Pedamallu, Fujiko Duke, Joaquim Bellmunt, Edward C. Stack, Lillian Werner, Rachel Park, Gopa Iyer, Massimo Loda, Philip W. Kantoff, Franziska Michor, Matthew Meyerson, Jonathan E. Rosenberg

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

Download from link.springer.com

Richard M. Bambury, David J. Benjamin, Joshua L. Chaim, Emily C. Zabor, John Sullivan, Ilana R. Garcia Grossman, Ashley M. Regazzi, Irina Ostrovnaya, Aryln Apollo, Han Xiao, Martin H. Voss, Gopa Iyer, Dean F. Bajorin, Jonathan E. Rosenberg

The Safety and Efficacy of Single-Agent Pemetrexed in Platinum-Resistant Advanced Urothelial Carcinoma: A Large Single-Institution Experience

Download from onlinelibrary.wiley.com

Wassim Abida, Dean F. Bajorin, Jonathan E. Rosenberg

First-Line Treatment and Prognostic Factors of Metastatic Bladder Cancer for Platinum-Eligible Patients

Upload

Guru Sonpavde, Gregory R. Pond, Jonathan E. Rosenberg

, Dean F. Bajorin, Ashley M. Regazzi, Toni K. Choueiri, Angela Q. Qu, Guenter Niegisch

, Peter Albers, Andrea Necchi, Giuseppe Di Lorenzo, Ronan Fougeray, Robert Dreicer, Yu-Hui Chen, Yu-Ning Wong and 5 other authors

Complete Response as an Intermediate End Point in Patients Receiving Salvage Systemic Therapy for Urothelial Carcinoma

Upload

Joaquim Bellmunt, Lillian Werner, Aristotle Bamias, André P. Fay, Rachel S. Park, Silvia de Muga, Markus Riester, Shamini Selvarajah, Justine A. Barletta, David M. Berman, Silvia de Muga, Marta Salido, Enrique Gallardo, Federico Rojo, Elizabeth A. Guancial

and 6 other authors

HER2 as a target in invasive urothelial carcinoma

Download from onlinelibrary.wiley.com

G. R. Pond, J. Bellmunt, J. E. Rosenberg

, D. F. Bajorin, A. M. Regazzi, T. K. Choueiri, A. Q. Qu, G. Niegisch

, P. Albers, A. Necchi, G. Di Lorenzo, R. Fougeray, Y.-N. Wong, S. S. Sridhar, Y.-J. Ko and 3 other authors

Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design

Upload

Philip H. Kim, Eugene K. Cha

, John P. Sfakianos, Gopa Iyer, Emily C. Zabor, Sasinya N. Scott, Irina Ostrovnaya, Ricardo Ramirez, Arony Sun, Ronak Shah

, Alyssa M. Yee, Victor E. Reuter, Dean F. Bajorin, Jonathan E. Rosenberg

, Nikolaus Schultz and 4 other authors

Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder

Download from europepmc.org

Andrea B. Apolo, Vanessa Hoffman, Matthew G. Kaag, David M. Latini, Cheryl T. Lee, Jonathan E. Rosenberg

, Margaret Knowles, Dan Theodorescu, Bogdan A. Czerniak, Jason A. Efstathiou, Matthew L. Albert, Srikala S. Sridhar, Vitaly Margulis, Surena F. Matin, Matthew D. Galsky and 7 other authors

Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward

Upload

Bishoy M. Faltas

, Beerinder S. Karir, Scott T. Tagawa, Jonathan E. Rosenberg

Novel molecular targets for urothelial carcinoma

Download from europepmc.org

Elizabeth A. Guancial, Jonathan E. Rosenberg

The Role of Genomics in the Management of Advanced Bladder Cancer

Download from link.springer.com

2014 Matthew I. Milowsky, Christian Dittrich, Ignacio Durán, Satinder Jagdev, Frederick E. Millard, Christopher J. Sweeney, Dean Bajorin, Linda Cerbone, David I. Quinn, Walter M. Stadler, Jonathan E. Rosenberg

, Melissa Lochheed, Paramita Sen, Matthew Squires, Michael Shi and 1 other authors

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

Download from www.researchgate.net

Guru Sonpavde, Joaquim Bellmunt, Jonathon E. Rosenberg

, Ashley M. Regazzi, Dean F. Bajorin, Toni K. Choueiri, Angela Q. Qu, Guenter Niegisch

, Peter Albers, Andrea Necchi, Giuseppe Di Lorenzo, Ronan Fougeray, Yu-Ning Wong, Srikala S. Sridhar, Yoo-Joung Ko and 3 other authors

Patient Eligibility and Trial Design for the Salvage Therapy of Advanced Urothelial Carcinoma

Upload

Elizabeth R. Plimack, Jean Hoffman-Censits, Jonathan E. Rosenberg

, Yu-Ning Wong, Cora N. Sternberg, Joaquim Bellmunt, Andrea B. Apolo, Toni K. Choueiri

Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

Download from doi.org

Eliezer M. Van Allen, Kent W. Mouw, Philip Kim, Gopa Iyer, Nikhil Wagle, Hikmat Al-Ahmadie

, Cong Zhu, Irina Ostrovnaya, Gregory V. Kryukov, Kevin W. O'Connor, Kevin W. O’Connor, John P. Sfakianos, Ilana Garcia-Grossman, Jaegil Kim, Elizabeth A. Guancial and 20 other authors

Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

Download from aacrjournals.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Jonathan Rosenberg